대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제1장 갑상선분화암의 수술 전 병기를 예측하기 위한 영상 및 혈액 검사 2024

키워드

참고문헌 (64)

1. Ha EJ, "2021 Korean Thyroid Imaging Reporting and Data System and imaging-based management of thyroid nodules : Korean Society of Thyroid Radiology consensus statement and recommendations", Korean J Radiol, 22(12), pp.2094~2123 (2021)
2. Expert Panel on Neurological Imaging, "ACR Appropriateness Criteria((R))thyroid disease", J Am Coll Radiol, 16(5S), pp.S300~S314 (2019)
3. Lee JY, "2020 imaging guidelines for thyroid nodules and differentiated thyroid cancer : Korean Society of Thyroid Radiology", Korean J Radiol, 22(5), pp.840~860 (2021)
4. Ha EJ, "Primary imaging test and appropriate biopsy methods for thyroid nodules : guidelines by Korean Society of Radiology and National Evidence-based Healthcare Collaborating Agency", Korean J Radiol, 19(4), pp.623~631 (2018)
5. Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
6. Takashima S, "Using MR imaging to predict invasion of the recurrent laryngeal nerve by thyroid carcinoma", AJR Am J Roentgenol, 180(3), pp.837~842 (2003)
7. Wang J, "Esophageal invasion by thyroid carcinomas : prediction using magnetic resonance imaging", J Comput Assist Tomogr, 27(1), pp.18~25 (2003)
8. Wang JC, "Tracheal invasion by thyroid carcinoma : prediction using MR imaging", AJR Am J Roentgenol, 177(4), pp.929~936 (2001)
9. Jeong SY, "Sonographic assessment of minor extrathyroidal extension of papillary thyroid microcarcinoma involving the posterior thyroid capsule", Eur Radiol, 32(9), pp.6090~6096 (2022)
10. Chung SR, "Sonographic assessment of the extent of extrathyroidal extension in thyroid cancer", Korean J Radiol, 21(10), pp.1187~1195 (2020)
11. Randolph GW, "The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension", Thyroid, 22(11), pp.1144~1152 (2012)
12. Wada N, "Lymph node metastasis from 259 papillary thyroid microcarcinomas : frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection", Ann Surg, 237(3), pp.399~407 (2003)
13. Shimamoto K, "Preoperative staging of thyroid papillary carcinoma with ultrasonography", Eur J Radiol, 29(1), pp.4~10 (1998)
14. Solorzano CC, "Surgeon-performed ultrasound in the management of thyroid malignancy", Am Surg, 70(7), pp.576~580 (2004)
15. O'Connell K, "The utility of routine preoperative cervical ultrasonography in patients undergoing thyroidectomy for differentiated thyroid cancer", Surgery, 154(4), pp.697~701 (2013)
16. Stulak JM, "Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer", Arch Surg, 141(5), pp.489~494 (2006)
17. Leboulleux S, "Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer", J Clin Endocrinol Metab, 92(9), pp.3590~3594 (2007)
18. Chung SR, "Sonographic diagnosis of cervical lymph node metastasis in patients with thyroid cancer and comparison of European and Korean guidelines for stratifying the risk of malignant lymph node", Korean J Radiol, 23(11), pp.1102~1111 (2022)
19. Lee JY, "Validation of ultrasound risk stratification systems for cervical lymph node metastasis in patients with thyroid cancer", Cancers(Basel), 14(9), pp.2106~ (2022)
20. Lee Y, "Value of CT added to ultrasonography for the diagnosis of lymph node metastasis in patients with thyroid cancer", Head Neck, 40(10), pp.2137~2148 (2018)
21. Suh CH, "Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer : a systematic review and meta-analysis", AJNR Am J Neuroradiol, 38(1), pp.154~161 (2017)
22. Alabousi M, "Diagnostic test accuracy of ultrasonography vs computed tomography for papillary thyroid cancer cervical lymph node metastasis : a systematic review and metaanalysis", JAMA Otolaryngol Head Neck Surg, 148(2), pp.107~118 (2022)
23. Jeon SJ, "Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer : correlations with US features", Korean J Radiol, 10(2), pp.106~111 (2009)
24. Cignarelli M, "Diagnostic utility of thyroglobulin detection in fine-needle aspiration of cervical cystic metastatic lymph nodes from papillary thyroid cancer with negative cytology", Thyroid, 13(12), pp.1163~1167 (2003)
25. Chung SR, "Diagnostic algorithm for metastatic lymph nodes of differentiated thyroid carcinoma", Cancers(Basel), 13(6), pp.1388~ (2021)
26. Cunha N, "Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes : a technique for the diagnosis of metastatic differentiated thyroid cancer", Eur J Endocrinol, 157(1), pp.101~107 (2007)
27. Chung J, "Optimal indication of thyroglobulin measurement in fineneedle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma", Head Neck, 36(6), pp.795~801 (2014)
28. Sun J, "The influence of thyroid status, serum Tg, TSH, and TgAb on FNA-Tg in cervical metastatic lymph nodes of papillary thyroid carcinoma", Laryngoscope Investig Otolaryngol, 7(1), pp.274~282 (2022)
29. Sigstad E, "The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay", Diagn Cytopathol, 35(12), pp.761~767 (2007)
30. Kim MJ, "Thyroglobulin measurement in fine-needle aspirate washouts : the criteria for neck node dissection for patients with thyroid cancer", Clin Endocrinol(Oxf), 70(1), pp.145~151 (2009)
31. Moon JH, "Thyroglobulin in washout fluid from lymph node fineneedle aspiration biopsy in papillary thyroid cancer : large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results", J Clin Endocrinol Metab, 98(3), pp.1061~1068 (2013)
32. Duval M, "Impact of serum TSH and anti-thyroglobulin antibody levels on lymph node fine-needle aspiration thyroglobulin measurements in differentiated thyroid cancer patients", Eur Thyroid J, 6(6), pp.292~297 (2017)
33. Repplinger D, "Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?", J Surg Res, 150(1), pp.49~52 (2008)
34. Suh I, "Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid", Am J Surg, 200(1), pp.41~46 (2010)
35. Lee EK, "Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules", J Korean Med Sci, 27(9), pp.1014~1018 (2012)
36. Youn I, "Serum thyroglobulin adds no additional value to ultrasonographic features in a thyroid malignancy", Ultrasound Q, 30(4), pp.287~290 (2014)
37. Patell R, "Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer : a retrospective cohort study", Endocrine, 61(3), pp.506~510 (2018)
38. Kars A, "Preoperative serum thyroglobulin level as a useful predictive marker to differentiate thyroid cancer", ORL J Otorhinolaryngol Relat Spec, 80(5-6), pp.290~295 (2018)
39. Wang L, "Preoperative serum thyrotropin to thyroglobulin ratio is effective for thyroid nodule evaluation in euthyroid patients", Otolaryngol Head Neck Surg, 153(1), pp.15~19 (2015)
40. Scheffler P, "Serum thyroglobulin improves the sensitivity of the McGill Thyroid Nodule Score for well-differentiated thyroid cancer", Thyroid, 24(5), pp.852~857 (2014)
41. Huang Z, "Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinoma", Ann Transl Med, 8(6), pp.389~ (2020)
42. Kim H, "Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer", Sci Rep, 7(1), pp.16955~ (2017)
43. Alhefdhi A, "Can preoperative serum thyroglobulin and antithyroglobulin levels predict malignant potential of a thyroid nodule with atypia or follicular lesion of undetermined significance?", Otorhinolaryngology-Head & Neck Surgery, 5(2), pp.1~4 (2020)
44. Trimboli P, "Preoperative measurement of serum thyroglobulin to predict malignancy in thyroid nodules : a systematic review", Horm Metab Res, 47(4), pp.247~252 (2015)
45. Alhozali A, "Prevalence and clinical significance of preoperative thyroglobulin antibodies in differentiated thyroid cancer patients", Open J Endocr Metab Dis, 12(11), pp.238~250 (2022)
46. Jia X, "Clinical analysis of preoperative anti-thyroglobulin antibody in papillary thyroid cancer between 2011 and 2015 in Beijing, China : a retrospective study", Front Endocrinol(Lausanne), 11, pp.452~ (2020)
47. Chen Z, "The utility of serum anti-thyroglobulin antibody and thyroglobulin in the preoperative differential diagnosis of thyroid follicular neoplasms", Endocrine, 76(2), pp.369~376 (2022)
48. Kaynak H, "The relationship between pre-operative anti-thyroglobulin antibody level and lymph node metastasis and recurrence in differentiated thyroid cancer", Turk J Oncol, 38(1), pp.29~35 (2023)
49. Jo K, "Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer", Clin Endocrinol(Oxf), 87(3), pp.292~299 (2017)
50. Shuai JH, "Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery", World J Clin Cases, 11(27), pp.6407~6414 (2023)
51. Li S, "The role of thyroglobulin in preoperative and postoperative evaluation of patients with differentiated thyroid cancer", Front Endocrinol(Lausanne), 13, pp.872527~ (2022)
52. Petric R, "Preoperative serum thyroglobulin concentration as a predictive factor of malignancy in small follicular and Hurthle cell neoplasms of the thyroid gland", World J Surg Oncol, 12, pp.282~ (2014)
53. fluoro-2-deoxy-D-glucose-positron emission tomography scanning, "J Clin Endocrinol Metab", 2006, 498~505
54. Rosenbaum-Krumme SJ, "18F-FDG PET", CT changes therapy management in high-risk DTC after first radioiodine therapy, 2012, pp.39(9), 1373~1380
55. Qiu ZL, "Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT", CT and 18F-FDG-PET, Nucl Med Commun, pp.2012, 33(12)[DOI]
56. Hong CM, "Distant metastatic lesions in patients with differentiated thyroid carcinoma. Clinical implications of radioiodine and FDG uptake", Nuklearmedizin, 52(4), pp.121~129 (2013)
57. Deandreis D, "Do histological, immunohistochemical, and metabolic(radioiodine and fluorodeoxyglucose uptakes)patterns of metastatic thyroid cancer correlate with patient outcome?", Endocr Relat Cancer, 18(1), pp.159~169 (2011)
58. Treglia G, "The role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer : an overview", Int J Endocrinol, 2013, pp.856189~ (2013)
59. Zampella E, "PET", CT in the management of differentiated thyroid cancer, 2021, pp.102(9), 515~523
60. Cracolici V, "No longer well-differentiated : diagnostic criteria and clinical importance of poorly differentiated", high-grade thyroid carcinoma, 2023, pp.16(1), 45~56
61. Vadrucci M, "18F-FDG PET", CT-guided clinical management of the rare aggressive"columnar-cell"variant of papillary thyroid cancer, 2016, pp.31(2), 343~344
62. Nascimento C, "Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography", computed tomography : an important imaging modality in patients with aggressive histology of differentiated thyroid cancer, 2015, pp.25(4), 437~444
63. Kim K, "Diagnostic values of F-18FDG PET or PET", CT, CT, and US for preoperative lymph node staging in thyroid cancer : a network meta-analysis, 2021, pp.94(1120), 20201076~
64. Lee CH, "Prognostic value of lymph node uptake on pretreatment F-18 FDG PET", CT in patients with N1b papillary thyroid carcinoma, 2019, pp.25(8), 787~793

관련 논문AI추천